These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25286554)

  • 1. [The current status of the resistance of malaria pathogens to antimalarials].
    Kondrashin AV; Baranova AM; Morozov EN; Morozova LF; Stepanova EV
    Med Parazitol (Mosk); 2014; (3):51-7. PubMed ID: 25286554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria historians: analyze your old slides!
    Sibley CH
    Trends Parasitol; 2006 Jun; 22(6):243-4. PubMed ID: 16632405
    [No Abstract]   [Full Text] [Related]  

  • 3. Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.
    Lo E; Nguyen J; Oo W; Hemming-Schroeder E; Zhou G; Yang Z; Cui L; Yan G
    BMC Infect Dis; 2016 Apr; 16():154. PubMed ID: 27084511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmodium falciparum and Plasmodium vivax genotypes and efficacy of intermittent preventive treatment in Papua New Guinea.
    Barnadas C; Senn N; Iga J; Timinao L; Javati S; Malau E; Rarau P; Reeder JC; Siba P; Karunajeewa H; Zimmerman PA; Davis TM; Mueller I
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6958-61. PubMed ID: 25155586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of malaria--a continuing challenge.
    Greenwood B
    N Engl J Med; 2014 Jul; 371(5):474-5. PubMed ID: 25075840
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoresistance of Plasmodium falciparum and Plasmodium vivax parasites in Brazil: consequences on disease morbidity and control.
    Gama BE; Lacerda MV; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2011 Aug; 106 Suppl 1():159-66. PubMed ID: 21881770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can estimates of antimalarial efficacy from field studies be improved?
    Gatton ML; Cheng Q
    Trends Parasitol; 2008 Feb; 24(2):68-73. PubMed ID: 18182325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can a single "powerless" mitochondrion in the malaria parasite contribute to parasite programmed cell death in the asexual stages?
    Ch'ng JH; Yeo SP; Shyong-Wei Tan K
    Mitochondrion; 2013 May; 13(3):254-6. PubMed ID: 23123916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
    Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic approaches to studying drug targets and resistance in Plasmodium.
    Cooper RA; Carucci DJ
    Curr Drug Targets Infect Disord; 2004 Mar; 4(1):41-51. PubMed ID: 15032633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of a regional observatory of malarial chemoresistance, an emerging public health problem in the Guyanas region].
    Esterre P; Volney B; Meynard JB; Legrand E
    Bull Soc Pathol Exot; 2009 Aug; 102(3):179-84. PubMed ID: 19739416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.
    Alam MT; Bora H; Bharti PK; Saifi MA; Das MK; Dev V; Kumar A; Singh N; Dash AP; Das B; Wajihullah ; Sharma YD
    Antimicrob Agents Chemother; 2007 Mar; 51(3):857-63. PubMed ID: 17194833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A database of antimalarial drug resistance.
    Sibley CH; Ringwald P
    Malar J; 2006 Jun; 5():48. PubMed ID: 16774688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.
    Barnadas C; Ratsimbasoa A; Tichit M; Bouchier C; Jahevitra M; Picot S; Ménard D
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4233-40. PubMed ID: 18809933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population genetics and drug resistance markers: an essential for malaria surveillance in Pakistan.
    Raza A; Beg MA
    J Coll Physicians Surg Pak; 2013 Dec; 23(12):878-84. PubMed ID: 24304992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and biological aspects of antimalarial resistance in Plasmodium falciparum and Plasmodium vivax.
    Bustamante C; Batista CN; Zalis M
    Curr Drug Targets; 2009 Mar; 10(3):279-90. PubMed ID: 19275564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimalarial ferroquine: from bench to clinic.
    Biot C; Nosten F; Fraisse L; Ter-Minassian D; Khalife J; Dive D
    Parasite; 2011 Aug; 18(3):207-14. PubMed ID: 21894260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.